Constellation Pharmaceuticals

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.

Company Growth (employees)

Type

Private

Cambridge, US

Founded

2008

Size (employees)

69 (est)+2%

Website

constellationpharma.com

Constellation Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US

Key People/Management at Constellation Pharmaceuticals

Jigar Raythatha

President & Chief Executive Officer

Matthias Jaffe

Chief Financial Officer

Mark A. Goldsmith

Executive Chairman

James Audia

Chief Scientific Officer

Brenda Sousa

Vice President of Human Resources

Constellation Pharmaceuticals Office Locations

Constellation Pharmaceuticals has an office in Cambridge

Cambridge, US (HQ)

215 First St

Constellation Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date	2008
Total Funding	$209.5 m
Latest funding size	$55 m
Time since last funding	almost 2 years
Investors	Altitude Life Science Ventures, The Column Group, Venrock, SR One, Genentech, Solon Mack Capital, Third Rock Ventures

Constellation Pharmaceuticals's latest funding round in December 2015 was reported to be $55 m. In total, Constellation Pharmaceuticals has raised $209.5 m